250 related articles for article (PubMed ID: 31545292)
1. The role and prospect of JMJD3 in stem cells and cancer.
Yin X; Yang S; Zhang M; Yue Y
Biomed Pharmacother; 2019 Oct; 118():109384. PubMed ID: 31545292
[TBL] [Abstract][Full Text] [Related]
2. EZH2, JMJD3, and UTX epigenetically regulate hepatic plasticity inducing retro-differentiation and proliferation of liver cells.
Pediconi N; Salerno D; Lupacchini L; Angrisani A; Peruzzi G; De Smaele E; Levrero M; Belloni L
Cell Death Dis; 2019 Jul; 10(7):518. PubMed ID: 31285428
[TBL] [Abstract][Full Text] [Related]
3. H3K27me3 demethylases regulate in vitro chondrogenesis and chondrocyte activity in osteoarthritis.
Yapp C; Carr AJ; Price A; Oppermann U; Snelling SJ
Arthritis Res Ther; 2016 Jul; 18(1):158. PubMed ID: 27388528
[TBL] [Abstract][Full Text] [Related]
4. Histone demethylase Jmjd3 modulates osteoblast apoptosis induced by tumor necrosis factor-alpha through directly targeting RASSF5.
Sun HY; Yang D; Mi J; Yu YQ; Qiu LH
Connect Tissue Res; 2020 Nov; 61(6):517-525. PubMed ID: 31092054
[No Abstract] [Full Text] [Related]
5. Regulation of the JMJD3 (KDM6B) histone demethylase in glioblastoma stem cells by STAT3.
Sherry-Lynes MM; Sengupta S; Kulkarni S; Cochran BH
PLoS One; 2017; 12(4):e0174775. PubMed ID: 28384648
[TBL] [Abstract][Full Text] [Related]
6. UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development.
Agger K; Cloos PA; Christensen J; Pasini D; Rose S; Rappsilber J; Issaeva I; Canaani E; Salcini AE; Helin K
Nature; 2007 Oct; 449(7163):731-4. PubMed ID: 17713478
[TBL] [Abstract][Full Text] [Related]
7. Effects of GSK-J4 on JMJD3 Histone Demethylase in Mouse Prostate Cancer Xenografts.
Sanchez A; Penault-Llorca F; Bignon YJ; Guy L; Bernard-Gallon D
Cancer Genomics Proteomics; 2022; 19(3):339-349. PubMed ID: 35430567
[TBL] [Abstract][Full Text] [Related]
8. New insights into the role of Jmjd3 and Utx in axial skeletal formation in mice.
Naruse C; Shibata S; Tamura M; Kawaguchi T; Abe K; Sugihara K; Kato T; Nishiuchi T; Wakana S; Ikawa M; Asano M
FASEB J; 2017 Jun; 31(6):2252-2266. PubMed ID: 28188179
[TBL] [Abstract][Full Text] [Related]
9. The histone H3 lysine-27 demethylase Jmjd3 plays a critical role in specific regulation of Th17 cell differentiation.
Liu Z; Cao W; Xu L; Chen X; Zhan Y; Yang Q; Liu S; Chen P; Jiang Y; Sun X; Tao Y; Hu Y; Li C; Wang Q; Wang Y; Chen CD; Shi Y; Zhang X
J Mol Cell Biol; 2015 Dec; 7(6):505-16. PubMed ID: 25840993
[TBL] [Abstract][Full Text] [Related]
10. The localization of histone H3K27me3 demethylase Jmjd3 is dynamically regulated.
Kamikawa YF; Donohoe ME
Epigenetics; 2014 Jun; 9(6):834-41. PubMed ID: 24646476
[TBL] [Abstract][Full Text] [Related]
11. Vitamin C-dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition.
Zhang T; Huang K; Zhu Y; Wang T; Shan Y; Long B; Li Y; Chen Q; Wang P; Zhao S; Li D; Wu C; Kang B; Gu J; Mai Y; Wang Q; Li J; Zhang Y; Liang Z; Guo L; Wu F; Su S; Wang J; Gao M; Zhong X; Liao B; Chen J; Zhang X; Shu X; Pei D; Nie J; Pan G
J Biol Chem; 2019 Sep; 294(37):13657-13670. PubMed ID: 31341023
[TBL] [Abstract][Full Text] [Related]
12. Different expression patterns of histone H3K27 demethylases in renal cell carcinoma and bladder cancer.
Hong Z; Li H; Li L; Wang W; Xu T
Cancer Biomark; 2017; 18(2):125-131. PubMed ID: 27983522
[TBL] [Abstract][Full Text] [Related]
13. H3K27me3 Demethylase UTX Restrains Plasma Cell Formation.
Kania AK; Price MJ; George-Alexander LE; Patterson DG; Hicks SL; Scharer CD; Boss JM
J Immunol; 2022 Apr; 208(8):1873-1885. PubMed ID: 35346967
[TBL] [Abstract][Full Text] [Related]
14. JMJD3 suppresses stem cell-like characteristics in breast cancer cells by downregulation of Oct4 independently of its demethylase activity.
Xun J; Wang D; Shen L; Gong J; Gao R; Du L; Chang A; Song X; Xiang R; Tan X
Oncotarget; 2017 Mar; 8(13):21918-21929. PubMed ID: 28423536
[TBL] [Abstract][Full Text] [Related]
15. JMJD3 as an epigenetic regulator in development and disease.
Burchfield JS; Li Q; Wang HY; Wang RF
Int J Biochem Cell Biol; 2015 Oct; 67():148-57. PubMed ID: 26193001
[TBL] [Abstract][Full Text] [Related]
16. GSK-J4: An H3K27 histone demethylase inhibitor, as a potential anti-cancer agent.
Dalpatraj N; Naik A; Thakur N
Int J Cancer; 2023 Sep; 153(6):1130-1138. PubMed ID: 37165737
[TBL] [Abstract][Full Text] [Related]
17. Expression and significance of histone H3K27 demethylases in renal cell carcinoma.
Shen Y; Guo X; Wang Y; Qiu W; Chang Y; Zhang A; Duan X
BMC Cancer; 2012 Oct; 12():470. PubMed ID: 23057811
[TBL] [Abstract][Full Text] [Related]
18. Emerging roles of JMJD3 in cancer.
Farzaneh M; Kuchaki Z; Rashid Sheykhahmad F; Meybodi SM; Abbasi Y; Gholami E; Ghaedrahmati F; Anbiyaee O
Clin Transl Oncol; 2022 Jul; 24(7):1238-1249. PubMed ID: 35239138
[TBL] [Abstract][Full Text] [Related]
19. Histone demethylase JMJD3 regulates CD11a expression through changes in histone H3K27 tri-methylation levels in CD4+ T cells of patients with systemic lupus erythematosus.
Yin H; Wu H; Zhao M; Zhang Q; Long H; Fu S; Lu Q
Oncotarget; 2017 Jul; 8(30):48938-48947. PubMed ID: 28430662
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of H3K27me3 Demethylases Promotes Plasmablast Formation.
Kania AK; Guo M; Scharer CD; Boss JM
Immunohorizons; 2021 Dec; 5(12):918-930. PubMed ID: 34880105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
